NVC-422 Also Shown Effective Against Six Other Highly Drug-Resistant Pathogens EMERYVILLE, Calif., Jan. 6, 2011 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals (NYSE Amex:NBY), a clinical stage ...

In a study to identify risk factors and outcomes in extended-spectrum beta-lactamose-producing Enterobacteriaceae infections in pediatric patients, researchers found 77 percent of the infections were ...

Objective: Neonatal colonization of the gut with multiresistant (ESBL= Extended spectrum betalactamase) gram-negative bacteria has become more common in recent years. The aim of this study was to ...

Populating the gastrointestinal tracts of mice with Bacteroides species producing a specific enzyme helps protect the good commensal bacteria from the harmful effects of antibiotics, researchers have ...

Please provide your email address to receive an email when new articles are posted on . Gram-negative bacillary (GNB) resistance is increasing worldwide, leaving clinicians with challenging treatment ...

In a recent study published in the Microbiology Spectrum Journal, researchers suggest that Escherichia coli ST2797 could potentially be a new type of extended-spectrum beta-lactamase (ESBL) ...

To date, our understanding of the epidemiology of KPC resistance is limited to outbreaks and infections reported from tertiary care academic medical centers. The epidemiology of KPC infections in the ...

Please provide your email address to receive an email when new articles are posted on . Emblaveo is the first monobactam/beta-lactamase inhibitor and antibiotic combination approved for this condition ...

Antibiotics are life-saving drugs, but they can also harm the beneficial microbes that live in the human gut, and this can put some patients at risk of developing inflammation or opportunistic ...